Fascia Iliaca Nerve Block Group for Hip Osteoarthritis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Hip Osteoarthritis+1 MorePericapsular Nerve Block - Other
Eligibility
18 - 80
All Sexes
What conditions do you have?
Select

Study Summary

This trial found that the pericapsular nerve block is more effective than the fascia iliaca nerve block for managing postoperative pain after total hip arthroplasty.

Eligible Conditions
  • Hip Osteoarthritis
  • Hip Arthritis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Intervention Group
1
Bupivacaine Hydrochloride 0.25% Injection Solution_#2
1
IT Injection

Study Objectives

2 Primary · 6 Secondary · Reporting Duration: Surgery to 1 month post surgery

Hour 48
Distance upon first ambulation
Hour 48
Time to first opioid medication
Hour 48
Incidence of weakness and falls
Time to first ambulation
Hour 48
Change in Visual Analog Pain Scale (VAS) Score
Last preoperative visit to four weeks post-operation
12 Item Short Form Health Survey Version 2
Harris Hip Score
Month 1
Postoperative Opioid Consumption in mg

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Intervention Group
1
Bupivacaine Hydrochloride 0.25% Injection Solution_#2
1
IT Injection

Trial Design

2 Treatment Groups

Fascia Iliaca Nerve Block Group
1 of 2
Pericapsular Nerve Block Group
1 of 2

Active Control

78 Total Participants · 2 Treatment Groups

Primary Treatment: Fascia Iliaca Nerve Block Group · No Placebo Group · N/A

Fascia Iliaca Nerve Block Group
Other
ActiveComparator Group · 1 Intervention: Fascia Iliaca Nerve Block · Intervention Types: Other
Pericapsular Nerve Block Group
Other
ActiveComparator Group · 1 Intervention: Pericapsular Nerve Block · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: surgery to 1 month post surgery

Who is running the clinical trial?

LifeBridge HealthLead Sponsor
27 Previous Clinical Trials
3,890 Total Patients Enrolled
Rubin Institute for Advanced OrthopedicsUNKNOWN
1 Previous Clinical Trials
100 Total Patients Enrolled
Ronald Delanois, MDPrincipal InvestigatorLifeBridge Health
2 Previous Clinical Trials
738 Total Patients Enrolled

Eligibility Criteria

Age 18 - 80 · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top